Total Payments
$2,958
2024 Payments
$604.46
Companies
17
Transactions
106
Medicare Patients
3,522
Medicare Billing
$217,552
Payment Breakdown by Category
Food & Beverage$2,855 (96.5%)
Education$99.99 (3.4%)
Travel$2.63 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,855 | 104 | 96.5% |
| Education | $99.99 | 1 | 3.4% |
| Travel and Lodging | $2.63 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $919.73 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $374.06 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $360.46 | 18 | $0 (2024) |
| GENZYME CORPORATION | $244.92 | 7 | $0 (2024) |
| Amgen Inc. | $225.76 | 8 | $0 (2024) |
| Lilly USA, LLC | $198.11 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $167.69 | 6 | $0 (2024) |
| Dermavant Sciences, Inc. | $112.08 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $82.75 | 3 | $0 (2024) |
| Incyte Corporation | $56.32 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $604.46 | 20 | Novartis Pharmaceuticals Corporation ($145.85) |
| 2023 | $705.94 | 19 | ABBVIE INC. ($220.01) |
| 2022 | $1,037 | 46 | ABBVIE INC. ($278.89) |
| 2021 | $609.97 | 21 | AbbVie Inc. ($280.58) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2024 | E.R. Squibb & Sons, L.L.C. | REYATAZ (Drug) | Food and Beverage | Cash or cash equivalent | $30.15 | General |
| Category: Virology | ||||||
| 05/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Inflammation | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Dermatology | ||||||
| 03/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CNS | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Dermatology | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Inflammation | ||||||
| 02/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.96 | General |
| Category: Immunology | ||||||
| 02/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $42.41 | General |
| Category: Immunology | ||||||
| 01/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.75 | General |
| Category: Immunology | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $96.94 | General |
| 01/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Immunology | ||||||
| 12/22/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.12 | General |
| Category: Immunology | ||||||
| 12/15/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Immunology | ||||||
| 11/30/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $112.08 | General |
| Category: DERMATOLOGY | ||||||
| 11/17/2023 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Dermatology | ||||||
| 11/15/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.26 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 548 | 827 | $193,326 | $30,919 |
| 2022 | 13 | 1,335 | 2,142 | $535,427 | $83,171 |
| 2021 | 14 | 1,410 | 2,161 | $533,974 | $89,046 |
| 2020 | 8 | 229 | 307 | $53,390 | $14,417 |
Total Patients
3,522
Total Services
5,437
Medicare Billing
$217,552
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 173 | $54,495 | $9,745 | 17.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 91 | 93 | $39,711 | $6,021 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 54 | $24,894 | $4,199 | 16.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 92 | 102 | $28,662 | $3,311 | 11.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 34 | 35 | $16,695 | $2,542 | 15.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 17 | 18 | $11,772 | $2,148 | 18.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 65 | 309 | $7,725 | $1,409 | 18.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 29 | $6,670 | $1,033 | 15.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $2,702 | $511.03 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 385 | 491 | $154,955 | $25,827 | 16.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 189 | 217 | $92,659 | $13,670 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 112 | $51,632 | $8,900 | 17.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 211 | 256 | $71,936 | $8,797 | 12.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 90 | 101 | $48,177 | $7,412 | 15.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 32 | 43 | $28,122 | $4,719 | 16.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 150 | 721 | $18,025 | $3,317 | 18.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 51 | 71 | $16,330 | $2,612 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $19,780 | $2,581 | 13.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 51 | $9,843 | $1,764 | 17.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 13 | 13 | $9,880 | $1,693 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $7,656 | $1,194 | 15.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 12 | 12 | $6,432 | $686.26 | 10.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 241 | 272 | $109,789 | $18,484 | 16.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 267 | 289 | $88,619 | $16,615 | 18.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 119 | 119 | $52,088 | $8,163 | 15.7% |
About Kaila Sinclair, NP
Kaila Sinclair, NP is a Family healthcare provider based in Plymouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2018. The National Provider Identifier (NPI) number assigned to this provider is 1689166126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kaila Sinclair, NP has received a total of $2,958 in payments from pharmaceutical and medical device companies, with $604.46 received in 2024. These payments were reported across 106 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,855).
As a Medicare-enrolled provider, Sinclair has provided services to 3,522 Medicare beneficiaries, totaling 5,437 services with total Medicare billing of $217,552. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Dermatology
- Location Plymouth, MA
- Active Since 05/31/2018
- Last Updated 11/03/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689166126
Products in Payments
- SKYRIZI (Biological) $570.44
- TREMFYA (Drug) $314.33
- DUPIXENT (Biological) $291.37
- Otezla (Drug) $225.76
- COSENTYX (Biological) $214.61
- HUMIRA (Biological) $204.83
- Sotyktu (Drug) $137.54
- RINVOQ (Biological) $124.92
- VTAMA (Drug) $112.08
- TALTZ (Drug) $70.35
- SPEVIGO (Drug) $59.77
- REMICADE (Biological) $59.73
- OPZELURA (Drug) $56.32
- COSENTYX (Drug) $48.91
- ADBRY (Biological) $46.14
- REYATAZ (Drug) $30.15
- BLU-U (Medical Supply) $29.19
- YCANTH (Drug) $24.13
- CYLTEZO (Biological) $22.98
- EUCRISA (Drug) $22.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Plymouth
Kyle Farr, Np-C, NP-C
Family — Payments: $200,487
Family $200,487
Mrs. Candie Books, Fnp-C, FNP-C
Family — Payments: $10,392
Family $10,392
Mrs. Brittany Walsh, Fnp, FNP
Family — Payments: $6,026
Family $6,026
Marla Troyer, Fnp, FNP
Family — Payments: $5,916
Family $5,916
Kathleen Brodt, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $5,057
Family $5,057
Glenda Ensweiler, Np, NP
Family — Payments: $4,989
Family $4,989